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Acta Dermatovenerol Croat 2015;23(1):63-65                                 LETTER TO THE EDITOR
Ashy dermatosis or erythema dyschromicum 
perstans (EDP) is a typically asymptomatic disease 
of unknown origin that causes symmetrical gray 
spots on the trunk and extremities (1). It was first 
described by Ramirez in 1957 (2). Patients show 
oval, irregular, or polycyclic gray macules with 
erythematous, inflammatory borders (3). There is no 
single established therapy for EDP. 
The aim of our study was to evaluate the efficacy 
of narrowband UVB (nbUVB) phototherapy for the 
treatment of EDP.
We present two women, 53 and 59 years old, with a 
one-year history of progressive cutaneous pigmentary 
changes, were admitted to our Department. Initially, 
lesions presented as asymptomatic blue gray macules 
on the trunk, which slowly spread to her extremities. 
Both patients had a history of thyroid disease: the 
first presented with multiple nodules in both thyroid 
lobes, compatible with a diagnosis of multinodular 
goitre; the second had autoimmune thyroiditis. 
Physical examination revealed the presence of 
multiple bluish-gray macules with slight erythematous 
borders, non-pruriginous, on the trunk, abdomen, 
and extremities; the largest was 2 cm in diameter 
(Figure 1). Before coming to our Department, both 
patients  had received topical corticosteroid therapy 
(dexossimetazone 0.25%, twice a day) for 2 months, 
without any improvement. 
Figure 1. Multiple bluish-gray macules with slight erythematous borders
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In both cases the histological findings (biopsy from 
a lesion of the dorsum) showed a thinned epidermis, 
edema of the superficial dermis, neovascularization, 
and pigment incontinence; the histology was 
compatible with an acute inflammation (Figure 2). 
EDP was diagnosed in both patients and treated with 
nbUVB phototherapy for 12 sessions (three times a 
week for four weeks, total dose 4716 mJ/cm2, Daavlin® 
311 nm). 
After 12 sessions of nbUVB phototherapy, an 
improvement of the erythematous violaceous 
component was achieved. However, there was 
persistence of a slight grayish halo, although a 
reduction of erythematous borders was achieved. The 
gray halo lasted for six months after the last nbUVB 
session (Figure 3). 
The histology was repeated after 12 phototherapy 
sessions. In both cases the new biopsy showed 
different findings, with chronic inflammation areas 
characterized by a low vascular component and 
an increased cellularity, involving monocytes, 
macrophages, and plasma cells prevalent in the 
superficial dermis and the epidermis. There were no 
signs of acute inflammation and edema. Additionally, 
a reduction of melanin incontinence was found.
DisCUssioN 
EDP is a rare disorder characterized by 
asymptomatic, slowly progressive, ash-gray macular 
pigmentation of the skin. Most cases have been 
reported in Latin American and Indian patients, with 
a greater prevalence in women. The etiology of EDP 
remains unknown. Occasionally, the condition is 
associated with infections, the ingestion of toxins, of 
medications, and endocrinopathies (thyroid disease). 
Treatment options include topical and systemic 
steroid, keratolytics, hydroquinone, dapsone, 
antibiotics, retinoids, griseofulvin, ascorbic acid, 
chloroquine, estrogens, chemical peels, laser therapy, 
and clofazimine, with partial success (4).  
We report two cases of EDP successfully treated 
with nbUVB phototherapy. In the literature there 
is only one report of using nbUVB phototherapy 
for treatment of EDP (5). The reason for treating 
EDP with nbUVB phototherapy is the presence of 
an inflammatory infiltrate occurring in the disease. 
NB-UVB phototherapy, in fact, decreases peripheral 
natural killer cell activity, lymphocyte proliferation, 
and immune regulatory cytokine production by both 
Th1 (IL-2, IFN-g) and Th2 (IL-10) T-cell populations 
(6,7). nbUVB phototherapy provides clinical 
camouflage, which hides the dermal pigmentation 
by stimulating pigment production. In addition 
to hyperpigmentation, nbUVB phototherapy also 
induces thickening of the stratum corneum and 
apoptosis of T lymphocytes (5). 
NbUVB phototherapy, in our case, led to a partial 
fading of blue-gray pigmentation and a good response 
of inflammatory lesions. In conclusion, our cases 
provide support for the use of nbUVB in the treatment 
of EDP in relation to the inflammatory pathogenesis 
of the disease. Further studies are needed to better 
characterize the pathogenesis of the disease and 
confirm the effectiveness of phototherapy.
References
1. Hisayoshi I, Daisuke T, Hiromi K Hisayoshi , Masa-
mitsu I, Koichi N. Two cases of unilateral ashy aer-
matosis. Case Rep Dermatol. 2011;3:1-4.
2. Ramirez CO. Los cenicientos: Problema clinico. Pro-
ceedings of the First Central American Congress 
of Dermatology,1957; San Salvador. 1957:122-30.
3. Lapeere H, Boone B, Schepper SD, et al . Erythema 
dyschromicum perstans. In: Wolff K, Goldsmith L, 
Katz SI, Gilchrest BA, Paller AS, Leffell DJ, editors. 
Dermatology in General Medicine. Fitzpatrick’s 
Vol 1. New York: McGraw-Hill; 2008. p.64.
4. Novick NL, Phelps R, Tom C. Erithema dyschromi-
cum perstans. Int J Dermatol 1986;25:322-3.
5. Brook E, Tlougan BE, Gonzalez ME, Mandal RV, 
Kundu RV, Skopicki D. Erythema dyschromicum 
perstans. Dermatol Online J 2010;16:11-7. 
6. An appraisal of narrow band (TL-01) UVB phototh-
erapy. British Photodermatology Group Workshop 
Report (April 1996). Br J Dermatol 1997;137:327-
30.
Letter to the editor Acta Dermatovenerol Croat
  2015;23(1):63-65
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